ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...

Drug delivery has undergone a remarkable transformation from basic oral tablets to sophisticated, targeted systems that deliver treatments with unprecedented precision. Today's pharmaceutical ...

Expansion of Plainville, Mass., facility offers bioprocessing expertise, advanced technologies and customized supportWALTHAM, ...

The rapid evolution of screening platforms is transforming how laboratory professionals identify and validate therapeutic candidates. Implementing these advanced systems accelerates pipelines while ...

POLARIS qb is slashing the timeframes and costs of drug discovery by using the unique processing power of quantum technology to identify the best lead compounds for drug development. Traditional ...

Switching to camizestrant 75 mg while continuing CDK4/6i significantly prolonged PFS to 16.0 vs 9.2 months (HR 0.44; P<.00001 ...

In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...

New designer drug on the street and it was found in Richland County To stream WLTX 19 on your phone, you need the WLTX 19 app.

Recursion Pharmaceuticals' AI-driven Recursion OS platform shows strong potential but has yet to demonstrate a clear ...

Richland County coroner Rutherford found the drug during an overdose investigation--it's called Cyclorphine and it kills. Justice Department declares presidential records law unconstitutional, raising ...

A U.S. FDA advisory panel voted 6-3 against AstraZeneca’s bid to approve camizestrant for HR-positive, HER2-negative advanced breast cancer with ESR1 mutations detected before disease progression.